Opko Health’s (OPK) “Hold” Rating Reiterated at Jefferies Group
Opko Health Inc. (NYSE:OPK)‘s stock had its “hold” rating restated by stock analysts at Jefferies Group in a research note issued to investors on Monday. They presently have a $10.00 price target on the stock. Jefferies Group’s price objective would indicate a potential upside of 0.91% from the stock’s current price.
Several other brokerages have also issued reports on OPK. JPMorgan Chase & Co. set a $14.00 target price on Opko Health and gave the stock a “buy” rating in a research note on Tuesday, August 9th. Oppenheimer Holdings Inc. reaffirmed a “market perform” rating on shares of Opko Health in a research note on Thursday, August 11th. Zacks Investment Research raised Opko Health from a “sell” rating to a “hold” rating in a research note on Tuesday, July 12th. Deutsche Bank AG dropped their price objective on Opko Health from $11.00 to $10.00 and set a “hold” rating for the company in a research note on Thursday, June 16th. Finally, Standpoint Research increased their price objective on Opko Health from $16.00 to $18.00 and gave the company a “buy” rating in a research note on Tuesday, June 21st. Five analysts have rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus target price of $13.20.
Opko Health (NYSE:OPK) traded up 0.50% during mid-day trading on Monday, hitting $9.96. 1,029,773 shares of the stock traded hands. The firm has a market capitalization of $5.48 billion and a P/E ratio of 41.67. The company has a 50-day moving average of $10.06 and a 200 day moving average of $10.12. Opko Health has a 1-year low of $7.12 and a 1-year high of $11.85.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/10/10/opko-healths-opk-hold-rating-reiterated-at-jefferies-group.html
Opko Health (NYSE:OPK) last issued its earnings results on Monday, August 8th. The company reported $0.02 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.03) by $0.05. The firm earned $357.10 million during the quarter, compared to analysts’ expectations of $324.11 million. The firm’s quarterly revenue was up 742.2% compared to the same quarter last year. During the same period in the prior year, the company earned ($0.09) EPS. On average, equities research analysts anticipate that Opko Health will post ($0.05) EPS for the current year.
In other Opko Health news, CEO Phillip Md Et Al Frost bought 48,400 shares of the firm’s stock in a transaction that occurred on Thursday, August 25th. The stock was bought at an average price of $9.06 per share, for a total transaction of $438,504.00. Following the completion of the acquisition, the chief executive officer now directly owns 3,068,951 shares in the company, valued at $27,804,696.06. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.
A number of institutional investors have recently bought and sold shares of OPK. Commonwealth Equity Services Inc increased its position in Opko Health by 4.6% in the first quarter. Commonwealth Equity Services Inc now owns 56,358 shares of the company’s stock worth $586,000 after buying an additional 2,462 shares during the period. Aperio Group LLC increased its position in Opko Health by 67.1% in the first quarter. Aperio Group LLC now owns 63,042 shares of the company’s stock worth $655,000 after buying an additional 25,312 shares during the period. Virginia Retirement System purchased a new position in Opko Health during the first quarter worth about $510,000. Teachers Advisors Inc. increased its position in Opko Health by 3.6% in the first quarter. Teachers Advisors Inc. now owns 325,172 shares of the company’s stock worth $3,379,000 after buying an additional 11,403 shares during the period. Finally, BlackRock Inc. increased its position in Opko Health by 239.6% in the first quarter. BlackRock Inc. now owns 36,005 shares of the company’s stock worth $375,000 after buying an additional 25,403 shares during the period.
About Opko Health
OPKO Health, Inc (OPKO) is a healthcare company. The Company operates through two segments: diagnostics and pharmaceutical. The pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel and Spain, and its pharmaceutical research and development operations. The diagnostics segment primarily consists of its clinical laboratory operations.
Receive News & Ratings for Opko Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Opko Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.